Home LiteratureArticle Details
PMID: 16943564 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction.

Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK

Abstract

Mitochondrial dysfunction is one of the major intracellular lesions of Alzheimer's disease (AD). However, the causative factors involved in the mitochondrial dysfunction in human AD are not well understood. Here we report that nonglycosylated full-length and C-terminal truncated amyloid precursor protein (APP) accumulates exclusively in the protein import channels of mitochondria of human AD brains but not in age-matched controls. Furthermore, in AD brains, mitochondrially associated APP formed stable approximately 480 kDa complexes with the translocase of the outer mitochondrial membrane 40 (TOM40) import channel and a super complex of approximately 620 kDa with both mitochondrial TOM40 and the translocase of the inner mitochondrial membrane 23 (TIM23) import channel TIM23 in an "N(in mitochondria)-C(out cytoplasm)" orientation. Accumulation of APP across mitochondrial import channels, which varied with the severity of AD, inhibited the entry of nuclear-encoded cytochrome c oxidase subunits IV and Vb proteins, which was associated with decreased cytochrome c oxidase activity and increased levels of H2O2. Regional distribution of mitochondrial APP showed higher levels in AD-vulnerable brain regions, such as the frontal cortex, hippocampus, and amygdala. Mitochondrial accumulation of APP was also observed in the cholinergic, dopaminergic, GABAergic, and glutamatergic neuronal types in the category III AD brains. The levels of translocationally arrested mitochondrial APP directly correlated with mitochondrial dysfunction. Moreover, apolipoprotein genotype analysis revealed that AD subjects with the E3/E4 alleles had the highest content of mitochondrial APP. Collectively, these results suggest that abnormal accumulation of APP across mitochondrial import channels, causing mitochondrial dysfunction, is a hallmark of human AD pathology.

MeSH Terms
Alzheimer Disease/metabolism,physiopathology Amyloid beta-Protein Precursor/metabolism Apolipoprotein E3 Apolipoprotein E4 Apolipoproteins E/metabolism Biological Transport Brain/metabolism,physiopathology Cadaver Case-Control Studies Electron Transport Complex IV/metabolism Glycosylation Humans Hydrogen Peroxide/metabolism Mitochondria/metabolism Mitochondrial Membrane Transport Proteins/metabolism Mitochondrial Membranes/enzymology Mitochondrial Proteins/metabolism Neurons/metabolism Tissue Distribution
Chemicals
Amyloid beta-Protein Precursor Apolipoprotein E3 Apolipoprotein E4 Apolipoproteins E Mitochondrial Membrane Transport Proteins Mitochondrial Proteins Hydrogen Peroxide Electron Transport Complex IV
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Devi Latha
Department of Animal Biology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Prabhu Badanavalu M
Galati Domenico F
Avadhani Narayan G
Anandatheerthavarada Hindupur K
References (57)
57 references, click to expand
  1. The cholinergic hypothesis of Alzheimer's disease: a review of progress.
    J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):137-47 PMID: 10071091
  2. Prostate apoptosis response-4 production in synaptic compartments following apoptotic and excitotoxic insults: evidence for a pivotal role in mitochondrial dysfunction and neuronal degeneration.
    J Neurochem. 1999 Jun;72(6):2312-22 PMID: 10349840
  3. Translating cell biology into therapeutic advances in Alzheimer's disease.
    Nature. 1999 Jun 24;399(6738 Suppl):A23-31 PMID: 10392577
  4. The TIM17.23 preprotein translocase of mitochondria: composition and function in protein transport into the matrix.
    EMBO J. 1999 Jul 1;18(13):3667-75 PMID: 10393182
  5. Dual targeting of cytochrome P4502B1 to endoplasmic reticulum and mitochondria involves a novel signal activation by cyclic AMP-dependent phosphorylation at ser128.
    EMBO J. 1999 Oct 15;18(20):5494-504 PMID: 10523294
  6. Tissue variant effects of heme inhibitors on the mouse cytochrome c oxidase gene expression and catalytic activity of the enzyme complex.
    Eur J Biochem. 1999 Nov;266(1):191-200 PMID: 10542064
  7. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients.
    Neurobiol Aging. 2000 May-Jun;21(3):455-62 PMID: 10858595
  8. Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype.
    Ann Neurol. 2000 Sep;48(3):297-303 PMID: 10976635
  9. Effects of learning on cytochrome oxidase activity in cuttlefish brain.
    Neuroreport. 2001 Jan 22;12(1):113-6 PMID: 11201069
  10. Effects of apolipoprotein E (apoE) isoforms, beta-amyloid (Abeta) and apoE/Abeta complexes on protein kinase C-alpha (PKC-alpha) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts.
    Neurochem Int. 2001 Jun;38(7):615-25 PMID: 11290387
  11. Mitochondrial abnormalities in Alzheimer's disease.
    J Neurosci. 2001 May 1;21(9):3017-23 PMID: 11312286
  12. Effects of chronic sodium azide on brain and muscle cytochrome oxidase activity: a potential model to investigate environmental contributions to neurodegenerative diseases.
    J Toxicol Environ Health A. 2001 May 11;63(1):67-77 PMID: 11346134
  13. Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration.
    J Neurosci. 2001 Jul 1;21(13):4923-30 PMID: 11425920
  14. Transport of proteins into mitochondria.
    Rev Physiol Biochem Pharmacol. 2001;143:81-136 PMID: 11428265
  15. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.
    Neuron. 2001 Jun;30(3):665-76 PMID: 11430801
  16. Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome.
    Neuron. 2002 Feb 28;33(5):677-88 PMID: 11879646
  17. Apolipoprotein E: a major piece in the Alzheimer's disease puzzle.
    J Cell Mol Med. 2001 Jul-Sep;5(3):254-66 PMID: 12067484
  18. Characterization of the human heart mitochondrial proteome.
    Nat Biotechnol. 2003 Mar;21(3):281-6 PMID: 12592411
  19. Phosphorylation enhances mitochondrial targeting of GSTA4-4 through increased affinity for binding to cytoplasmic Hsp70.
    J Biol Chem. 2003 May 23;278(21):18960-70 PMID: 12646569
  20. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells.
    J Cell Biol. 2003 Apr 14;161(1):41-54 PMID: 12695498
  21. Apolipoprotein E binding to low density lipoprotein receptor-related protein-1 inhibits cell migration via activation of cAMP-dependent protein kinase A.
    J Biol Chem. 2003 Sep 19;278(38):36257-63 PMID: 12857755
  22. Glutamatergic systems in Alzheimer's disease.
    Int J Geriatr Psychiatry. 2003 Sep;18(Suppl 1):S15-21 PMID: 12973746
  23. The role of metals in neurodegenerative processes: aluminum, manganese, and zinc.
    Brain Res Bull. 2003 Nov 15;62(1):15-28 PMID: 14596888
  24. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  25. Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage.
    Neuromolecular Med. 2004;5(2):147-62 PMID: 15075441
  26. Molecular genetics of late-onset Alzheimer's disease.
    Ann Hum Genet. 2004 Jul;68(Pt 4):381-404 PMID: 15225164
  27. Functional reconstitution of gamma-secretase through coordinated expression of presenilin, nicastrin, Aph-1, and Pen-2.
    J Neurosci Res. 2004 Aug 1;77(3):309-22 PMID: 15248287
  28. Nitrogen disruption of synaptoneurosomes: an alternative method to isolate brain mitochondria.
    J Neurosci Methods. 2004 Aug 30;137(2):299-303 PMID: 15262074
  29. Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance.
    Am J Pathol. 2004 Sep;165(3):987-95 PMID: 15331422
  30. Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis.
    J Biol Chem. 2004 Nov 26;279(48):50310-20 PMID: 15371443
  31. Shaping the mitochondrial proteome.
    Biochim Biophys Acta. 2004 Dec 6;1659(2-3):212-20 PMID: 15576054
  32. Mitochondrial failures in Alzheimer's disease.
    Am J Alzheimers Dis Other Demen. 2004 Nov-Dec;19(6):345-52 PMID: 15633943
  33. Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42.
    J Neurosci. 2005 Jan 19;25(3):672-9 PMID: 15659604
  34. Presenilin function and gamma-secretase activity.
    J Neurochem. 2005 May;93(4):769-92 PMID: 15857382
  35. Single translation--dual destination: mechanisms of dual protein targeting in eukaryotes.
    EMBO Rep. 2005 May;6(5):420-5 PMID: 15864293
  36. Alzheimer's disease: interactions between cholinergic functions and beta-amyloid.
    Curr Alzheimer Res. 2004 Nov;1(4):241-8 PMID: 15975053
  37. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease.
    Neurobiol Aging. 2005 Oct;26(9):1235-44 PMID: 16023263
  38. Mitochondria take center stage in aging and neurodegeneration.
    Ann Neurol. 2005 Oct;58(4):495-505 PMID: 16178023
  39. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.
    FASEB J. 2005 Dec;19(14):2040-1 PMID: 16210396
  40. Are mitochondria critical in the pathogenesis of Alzheimer's disease?
    Brain Res Brain Res Rev. 2005 Nov;49(3):618-32 PMID: 16269322
  41. Protein kinase A-mediated phosphorylation modulates cytochrome c oxidase function and augments hypoxia and myocardial ischemia-related injury.
    J Biol Chem. 2006 Jan 27;281(4):2061-70 PMID: 16303765
  42. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
    Hum Mol Genet. 2006 May 1;15(9):1437-49 PMID: 16551656
  43. Cytochrome oxidase deficiency in Alzheimer's disease.
    Ann N Y Acad Sci. 1991;640:59-64 PMID: 1663716
  44. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease.
    J Neural Transm Park Dis Dement Sect. 1991;3(4):231-58 PMID: 1772577
  45. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form.
    Anal Biochem. 1991 Dec;199(2):223-31 PMID: 1812789
  46. Differential involvement of protein kinase C isozymes in Alzheimer's disease.
    J Neurosci. 1990 Jul;10(7):2113-24 PMID: 2376771
  47. Brain aluminum in aging and Alzheimer disease.
    Neurology. 1979 Jun;29(6):809-14 PMID: 572003
  48. The beta A4 amyloid precursor protein binding to copper.
    FEBS Lett. 1994 Jul 25;349(1):109-16 PMID: 7913895
  49. Regional brain effects of sodium azide treatment on cytochrome oxidase activity: a quantitative histochemical study.
    Metab Brain Dis. 1995 Dec;10(4):303-20 PMID: 8847994
  50. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders.
    Brain Res. 1996 Nov 4;738(2):265-74 PMID: 8955522
  51. Energy metabolism, oxidative stress and neuronal degeneration in Alzheimer's disease.
    Neurodegeneration. 1996 Dec;5(4):435-40 PMID: 9117559
  52. Protein kinase C activity and protein levels in Alzheimer's disease.
    Brain Res. 1997 Aug 1;764(1-2):75-80 PMID: 9295195
  53. The Tim core complex defines the number of mitochondrial translocation contact sites and can hold arrested preproteins in the absence of matrix Hsp70-Tim44.
    EMBO J. 1997 Sep 1;16(17):5408-19 PMID: 9312000
  54. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.
    Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S1-2 PMID: 9330978
  55. Targeting of NH2-terminal-processed microsomal protein to mitochondria: a novel pathway for the biogenesis of hepatic mitochondrial P450MT2.
    J Cell Biol. 1997 Nov 3;139(3):589-99 PMID: 9348277
  56. Mutant genes in familial Alzheimer's disease and transgenic models.
    Annu Rev Neurosci. 1998;21:479-505 PMID: 9530504
  57. Copper, iron and zinc in Alzheimer's disease senile plaques.
    J Neurol Sci. 1998 Jun 11;158(1):47-52 PMID: 9667777
Article Info
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
Abbr.
J Neurosci
ISSN
1529-2401
Published
2006-08-30
Pages
9057-68
Language
English
Region
United States
NLM ID
8102140
PMCID
PMC6675337
Subset
IM
Grants
NIA NIH HHS · R01 AG021920 · United States
NIGMS NIH HHS · R01 GM049683 · United States
NIA NIH HHS · AG 021920 · United States
NIGMS NIH HHS · GM49683 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com